These possibilities of a detailed elucidation of Wnt5A can offer new starting points for Wnt-based therapeutic approaches for lung diseases such as asthma, COPD, or IPF in the future. The gene discussed is WNT5A; the disease is idiopathic pulmonary fibrosis.